Oxycontin

A major opioid manufacturer vows to stop marketing the drugs that are at the forefront a nationwide opioid addiction crisis. Purdue Pharma will no longer market opioids, including Oxycontin, to doctors and their patients.

Purdue was recently served with lawsuits linking the drug maker to the ongoing opioid crisis.

Read more »

Martin Shkrell is not so bad after all. The 32-year-old hedge fund manager sparked a public outcry when he raised price of an anti-parasitic drug from $13.50 a pill to $750 a pill.

Shkreli purchased the rights to sell Daraprim, a drug that treats potentially deadly parasitic infections in the elderly, infants, and AIDS patients.

The 5,000% price increase drew sharp criticism from lawmakers as well as infectious disease specialists.

Read more »

Lawmakers and AIDS specialists are protesting the “overnight” increase of a drug that helps to battle parasitic infections in the elderly, infants, and AIDS patients.

The rights to the 62-year-old drug, called Daraprim, was purchased in August by Turing Pharmaceuticals, a small start-up company founded by Martin Shkreli.

Read more »

Female Sexual Libido pill

A pill that increases female sexual libido by boosting Dopamine in the brain has been rejected by the Food and Drug Administration (FDA), The Atlanta Journal-Constitution reports.

Sprout Pharmaceuticals plans to appeal again to the FDA to approve its drug flibanserin. The FDA questioned whether the drug’s benefits outweighed the risks including the side effects fatigue, dizziness and nausea.

Read more »

1